Covered recipient · General Payments record
RICARDO D PARRONDO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$14,996.67
- Reported across 102 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $982.15 | 11 |
| Consulting Fee | $659.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $905.16 | 4 |
| Celgene Corporation | $273.58 | 2 |
| PFIZER INC. | $200.12 | 3 |
| GlaxoSmithKline, LLC. | $169.48 | 2 |
| Acerta Pharma LLC | $92.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $92.81 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104373419 | CMS |
| Celgene Corporation | $147.18 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101158918 | CMS |
| Celgene Corporation | $126.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101158922 | CMS |
| GENZYME CORPORATION | $659.00 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139893102 | CMS |
| GENZYME CORPORATION | $31.16 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139893030 | CMS |
| GENZYME CORPORATION | $95.02 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139893046 | CMS |
| GENZYME CORPORATION | $119.98 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139893080 | CMS |
| GlaxoSmithKline, LLC. | $124.81 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115931035 | CMS |
| GlaxoSmithKline, LLC. | $44.67 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116336715 | CMS |
| PFIZER INC. | $114.53 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131299708 | CMS |
| PFIZER INC. | $7.48 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131897141 | CMS |
| PFIZER INC. | $78.11 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130878334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.